4//SEC Filing
MATTHEWS TERENCE H 4
Accession 0001567619-20-012095
CIK 0001236997other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:48 PM ET
Size
19.3 KB
Accession
0001567619-20-012095
Insider Transaction Report
Form 4
COUNTERPATH CORPCPAH
MATTHEWS TERENCE H
DirectorChairman10% Owner
Transactions
- Purchase
Common Shares
2020-06-10$3.51/sh+142,451$500,003→ 1,649,112 total(indirect: Wesley Clover International Corporation)
Holdings
- 7,838.7
Deferred Share Units
From: 2010-06-18→ Common (3,000 underlying) - 4,838.7
Deferred Share Units
From: 2009-12-14→ Common (4,838.7 underlying) - 13,262.5
Deferred Share Units
From: 2013-07-25→ Common (2,262.5 underlying) - 16,689.9
Deferred Share Units
From: 2014-07-11→ Common (3,427.4 underlying) - 23,901.2
Deferred Share Units
From: 2015-07-17→ Common (7,211.3 underlying) - 1,506,661(indirect: Wesley Clover International Corporation)
Common Shares
- 9,460.3
Deferred Share Units
From: 2011-07-25→ Common (1,621.6 underlying) - 39,246.2
Deferred Share Units
From: 2016-07-14→ Common (15,345 underlying) - 83,157.2
Deferred Share Units
From: 2019-11-04→ Common (12,509 underlying) - 70,648.2
Deferred Share Units
From: 2018-07-26→ Common (14,459 underlying) - 11,000
Deferred Share Units
From: 2012-07-19→ Common (1,539.7 underlying) - 56,189.2
Deferred Share Units
From: 2017-07-14→ Common (16,943 underlying)
Footnotes (2)
- [F1]Dr. Matthews owns 99.999% of the issued and outstanding voting shares of Wesley Clover International Corporation.
- [F2]Each deferred share unit is convertible into one common share of CounterPath Corporation at no additional cost. There is no expiry date. The deferred share units vest immediately.
Documents
Issuer
COUNTERPATH CORP
CIK 0001236997
Entity typeother
Related Parties
1- filerCIK 0001220385
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:48 PM ET
- Size
- 19.3 KB